Redhill Biopharma Ltd

NAS:RDHLHealthcarenasdaq_composite

$0.5073+1.22%At closeAt close · Wed 21 Oct · ≈ AED 1.86 · Market cap $4.32M · Next earnings Thu 18 Mar · Extended $0.5174 +1.99%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	42.7%	42.4%	46.1%	47.0%	60.3%	100.0%	—	—
Operating margin	−99.0%	−94.6%	−69.3%	193.4%	−181.7%	−2,765.4%	−2,765.4%	+0.0 pts
Net margin	−118.4%	−114.0%	−116.0%	366.2%	−102.8%	−150.0%	−150.0%	+0.0 pts
EBITDA margin	−85.4%	−73.5%	−35.9%	402.3%	−94.4%	−2,675.5%	—	—
Return on equity	−549.4%	−1,101.3%	148.1%	1,155.9%	176.6%	−10.1%	−10.1%	+0.0 pts
Return on assets	−42.3%	−53.9%	−45.1%	103.8%	−45.8%	−1.7%	−1.7%	+0.0 pts
Return on capital employed	−59.5%	−81.4%	111.0%	332.0%	349.6%	−129.1%	—	—
Debt / equity	6.3×	9.9×	−2.5×	0.6×	−0.1×	0.3×	0.3×	+0.0%
Debt / assets	48.2%	48.5%	77.2%	5.1%	2.0%	4.2%	—	—
Interest coverage	−5.1×	−4.9×	−1.0×	34.4×	−265.7×	−416.3×	—	—
Current ratio	1.0×	1.1×	0.4×	0.8×	0.5×	0.3×	0.3×	+0.0%
Quick ratio	0.9×	0.9×	0.4×	0.6×	0.4×	0.3×	—	—
Cash ratio	0.4×	0.4×	0.1×	0.3×	0.2×	0.2×	0.2×	+0.0%
Asset turnover	0.4×	0.5×	0.4×	0.3×	0.4×	0.0×	—	—
Inventory turnover	5.7×	3.3×	3.0×	0.8×	0.9×	—	—	—
Receivables turnover	2.2×	2.6×	1.6×	2.0×	2.3×	0.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—